Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.54 | N/A |
| PEG Ratio (TTM) | 0.57 | N/A |
| P/S Ratio (TTM) | 1.01 | N/A |
| P/B Ratio (TTM) | 1.26 | N/A |
| P/FCF Ratio (TTM) | 5.80 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.75 | N/A |
| Price to 5YR AVG FCF Ratio | 11.04 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.71% | N/A |
| ROE (TTM) | 8.53% | N/A |
| Net Profit Margin (TTM) | 6.55% | N/A |
| ROIC 5YR AVG | 5.43% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 228.36% | 290.84% | 183.61% |
| Revenue | 2.23% | 4.39% | 5.00% |
| Net Income | 230.42% | 302.59% | 189.33% |
| Cash Flow | 77.87% | 21,161.09% | 12,708.62% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.42 | N/A |
| Interest Coverage (TTM) | 9.97 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.36 | N/A |
| LTL to 5YR AVG FCF | 3.77 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.17% | N/A |